2(3H)-Furanone, 5,5-dibutyldihydro-
Common Name: |
2(3H)-Furanone, 5,5-dibutyldihydro- |
IUPAC Name: |
5,5-dibutyloxolan-2-one |
Molecular Formula: |
C12H22O2 |
SMILES: |
CCCCC1(CCC(=O)O1)CCCC |
Inchi: |
1S/C12H22O2/c1-3-5-8-12(9-6-4-2)10-7-11(13)14-12/h3-10H2,1-2H3 |
Inchi Key: |
KZEKELDMLDBVFV-UHFFFAOYSA-N |
Cas No: |
7774-47-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
198.30 |
Mass (g/mol) |
198.162 |
Molar Refractivity |
59.01 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
279.00 to 280.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.004 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
3.443 |
iLOGP |
2.93 |
XLOGP3 |
3.65 |
WLOGP |
3.44 |
MLOGP |
2.76 |
ESOL Log S |
-2.97 |
ESOL Solubility (mg/ml) |
0.211 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.89 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.81 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.92 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.032 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.545 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |